Endogenous suppression of integrin signaling
整合素信号传导的内源性抑制
基本信息
- 批准号:8705582
- 负责人:
- 金额:$ 28.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdaptor Signaling ProteinAdoptive TransferAffectAffinityAffinity ChromatographyAgonistBindingBiological AssayBlood CirculationBlood PlateletsBlood VesselsBone Marrow CellsCardiovascular DiseasesCellsCoagulation ProcessCollagenComplexCuesCytoplasmic GranulesCytoplasmic TailDataDefectDiseaseFibrinogenFibrinogen ReceptorsFluorescenceFluorescence Resonance Energy TransferGenerationsHemorrhageHemostatic functionImmunoglobulinsIn VitroInjuryIntegrin InhibitionIntegrinsKnock-in MouseKnockout MiceLasersMolecularMusMutationMyocardial InfarctionNamesPhenotypePhosphopeptidesPhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalPhysiological ProcessesPlant RootsPlatelet ActivationPlatelet aggregationPlayProcessProteinsRecruitment ActivityRegulationRestRoleSRC geneScaffolding ProteinSerineSignal TransductionSignaling MoleculeSite-Directed MutagenesisStrokeSystemTechniquesTestingTherapeutic InterventionThrombosisThromboxane A2ThrombusTyrosineTyrosine PhosphorylationWound Healingarteriolecombatcrosslinkin vivoin vivo Modelinhibitor/antagonistjunctional adhesion moleculemutantnew therapeutic targetnovelprotein complexpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Platelets are anucleated cells found in abundance in circulation and play an important role in the process of physiological hemostasis. However, unwanted platelet activation results in a pathological condition termed thrombosis, which is the root cause of major cardiovascular diseases such as myocardial infarction and stroke. During vascular injury, circulating platelets adhere to the exposed subendothelial proteins such as collagen and are activated. Activated platelets recruit more platelets by secreting ADP from their granules and by generation of thromboxane A2. Activated platelets form a stable plug through fibrinogen-dependent crosslinking of integrin ¿IIb¿3. This process is tightly regulated and any defect in this regulation can result in impaired platelet activation resulting in bleeding disorder. For this reason, understanding the mechanisms surrounding platelet activation is essential. Platelets are kept in an unstimulated state by little-known anti-stimulatory mechanisms. During vascular injury, pro-stimulatory mechanisms, such as signaling by various physiological agonists, override the anti-stimulatory machinery to achieve platelet aggregation. We have identified a novel protein named JAM-A, which is expressed on platelets and negatively regulates platelet function. JAM-A binds to integrin ¿IIb¿3 and suppresses its activation and signaling. How the interaction of JAM-A with the integrin affects platelet function is not well understood and is the focus of this proposed application. We hypothesize that JAM-A is an endogenous inhibitor of integrin activation, and affects integrin outside in signaling. To test thi hypothesis, we will use Jam-A knockout mice and evaluate the molecular mechanisms through which JAM-A suppresses platelet activation and thus thrombosis.
描述(申请人提供):血小板是循环中大量存在的无核细胞,在生理止血过程中起重要作用。然而,不必要的血小板激活导致称为血栓形成的病理状态,这是主要心血管疾病如心肌梗死和中风的根本原因。在血管损伤期间,循环血小板粘附在暴露的内皮蛋白(如胶原蛋白)上并被激活。活化的血小板通过从颗粒中分泌ADP和生成血栓素A2来招募更多的血小板。活化的血小板通过纤维蛋白原依赖的整合素交联形成稳定的栓子。这一过程受到严格的调控,而这一调控中的任何缺陷都可能导致血小板活化受损,从而导致出血性疾病。因此,了解血小板活化的机制至关重要。血小板通过一种鲜为人知的抗刺激机制保持在一种不受刺激的状态。在血管损伤过程中,促刺激机制,如各种生理激动剂的信号传导,覆盖抗刺激机制,实现血小板聚集。我们发现了一种名为JAM-A的新蛋白,它在血小板上表达并负调控血小板功能。JAM-A结合整合素ib1 - 3并抑制其激活和信号传导。JAM-A与整合素的相互作用如何影响血小板功能尚不清楚,这是本应用的重点。我们假设JAM-A是一种内源性整合素激活抑制剂,并影响整合素的外部信号传导。为了验证这一假设,我们将使用Jam-A敲除小鼠,并评估Jam-A抑制血小板活化从而抑制血栓形成的分子机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ULHAS P NAIK其他文献
ULHAS P NAIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ULHAS P NAIK', 18)}}的其他基金
Regulation of Platelet Reactivity by S1P Signaling
S1P 信号传导调节血小板反应性
- 批准号:
10436813 - 财政年份:2019
- 资助金额:
$ 28.49万 - 项目类别:
ASK1 a novel regulator of platelet function
ASK1 一种新型血小板功能调节剂
- 批准号:
10383745 - 财政年份:2019
- 资助金额:
$ 28.49万 - 项目类别:
Regulation of Platelet Reactivity by S1P Signaling
S1P 信号传导调节血小板反应性
- 批准号:
10183303 - 财政年份:2019
- 资助金额:
$ 28.49万 - 项目类别:
ASK1 a novel regulator of platelet function
ASK1 一种新型血小板功能调节剂
- 批准号:
9899282 - 财政年份:2019
- 资助金额:
$ 28.49万 - 项目类别:
Ask1 a novel regulator of platelet function
Ask1 一种新型血小板功能调节剂
- 批准号:
8605910 - 财政年份:2013
- 资助金额:
$ 28.49万 - 项目类别:
Ask1 a novel regulator of platelet function
Ask1 一种新型血小板功能调节剂
- 批准号:
9034654 - 财政年份:2013
- 资助金额:
$ 28.49万 - 项目类别:
Ask1 a novel regulator of platelet function
Ask1 一种新型血小板功能调节剂
- 批准号:
8793808 - 财政年份:2013
- 资助金额:
$ 28.49万 - 项目类别: